Business Description
GL Pharm Tech Corp
ISIN : KR7204840003
Compare
Compare
Traded in other countries / regions
204840.Korea IPO Date
2014-11-20Description
GL Pharm Tech Corp is engaged in developing and marketing pharmaceutical products. It offers products including Incrementally Modified Drugs, Generic Drug and G-SOREN Tab. It also provides generic drugs for cardiovascular, gastric, diabetes, CNS, and respiratory diseases.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.81 | |||||
| Debt-to-EBITDA | 16.45 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.73 | |||||
| Beneish M-Score | -1.77 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 15.9 | |||||
| 3-Year EBITDA Growth Rate | -2 | |||||
| 3-Year EPS without NRI Growth Rate | 11.8 | |||||
| 3-Year FCF Growth Rate | 6.2 | |||||
| 3-Year Book Growth Rate | -12.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.17 | |||||
| 9-Day RSI | 42.67 | |||||
| 14-Day RSI | 40.99 | |||||
| 6-1 Month Momentum % | -8.23 | |||||
| 12-1 Month Momentum % | -28.31 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.53 | |||||
| Quick Ratio | 1.53 | |||||
| Days Inventory | 166.65 | |||||
| Days Sales Outstanding | 67.49 | |||||
| Days Payable | 63.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -9.7 | |||||
| Shareholder Yield % | -13.57 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 36.77 | |||||
| Operating Margin % | -1.43 | |||||
| Net Margin % | -13.73 | |||||
| FCF Margin % | -19.28 | |||||
| ROE % | -20.05 | |||||
| ROA % | -8.06 | |||||
| ROIC % | -0.98 | |||||
| ROC (Joel Greenblatt) % | -1.87 | |||||
| ROCE % | -1.37 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.86 | |||||
| PB Ratio | 3.99 | |||||
| Price-to-Tangible-Book | 3.98 | |||||
| EV-to-EBIT | -214.87 | |||||
| EV-to-EBITDA | 87.5 | |||||
| EV-to-Revenue | 3.39 | |||||
| EV-to-FCF | -17.31 | |||||
| Earnings Yield (Greenblatt) % | -0.47 | |||||
| FCF Yield % | -6.18 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GL Pharm Tech Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 24,900.201 | ||
| EPS (TTM) (â‚©) | -50.533 | ||
| Beta | 0.91 | ||
| Volatility % | 54.3 | ||
| 14-Day RSI | 40.99 | ||
| 14-Day ATR (â‚©) | 35.160873 | ||
| 20-Day SMA (â‚©) | 1030.65 | ||
| 12-1 Month Momentum % | -28.31 | ||
| 52-Week Range (â‚©) | 974 - 1540 | ||
| Shares Outstanding (Mil) | 76.7 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
GL Pharm Tech Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
GL Pharm Tech Corp Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
GL Pharm Tech Corp Frequently Asked Questions
What is GL Pharm Tech Corp(XKRX:204840)'s stock price today?
The current price of XKRX:204840 is â‚©1015.00. The 52 week high of XKRX:204840 is â‚©1540.00 and 52 week low is â‚©974.00.
When is next earnings date of GL Pharm Tech Corp(XKRX:204840)?
The next earnings date of GL Pharm Tech Corp(XKRX:204840) is .
Does GL Pharm Tech Corp(XKRX:204840) pay dividends? If so, how much?
GL Pharm Tech Corp(XKRX:204840) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers